CXCR2 and neoplasm: Research has shown that chemokine receptor agonists CXCR1 and CXCR2, produced by tumor cells, induce the formation of NETs, which act as a shield protecting tumor cells against cytotoxicity mediated by natural killer (NK) cells and T cells.